Literature DB >> 31564593

Prosthesis-Patient Mismatch Following Transcatheter Aortic Valve Replacement With Supra-Annular and Intra-Annular Prostheses.

Taishi Okuno1, Faisal Khan1, Masahiko Asami1, Fabien Praz1, Dik Heg2, Mirjam Gauri Winkel1, Jonas Lanz1, Adrian Huber3, Christoph Gräni1, Lorenz Räber1, Stefan Stortecky1, Marco Valgimigli1, Stephan Windecker1, Thomas Pilgrim4.   

Abstract

OBJECTIVES: This study sought to compare the frequency of prosthesis-patient mismatch (PPM) with self-expandable valves (SEV) to balloon-expandable valves (BEV).
BACKGROUND: PPM has been associated with increased mortality after transcatheter aortic valve replacement. Data on the frequency of PPM as a function of supra-annular or intra-annular position of transcatheter heart valves are insufficient.
METHODS: A total of 757 patients treated with SEV (CoreValve, Evolut R) and BEV (SAPIEN THV/XT/3) were enrolled in the present analysis between August 2007 and June 2017. PPM was classified based on discharge prosthetic effective orifice area indexed to body surface area (BSA) as severe (<0.65 cm2/m2) or moderate (0.65 to 0.85 cm2/m2) in the general population, and as severe (<0.60 cm2/m2) or moderate (0.60 to 0.90 cm2/m2) in the obese population (body mass index ≥30 kg/m2).
RESULTS: Propensity score matching resulted in 224 matched pairs. At discharge, SEV were associated with a lower incidence of PPM compared with BEV (PPM, 33.5% vs. 46.9%; p = 0.004; severe PPM, 6.7% vs. 15.6%; p = 0.003). The lower frequency of severe PPM in SEV was observed even in patients with larger annulus. Although patients with BSA >1.83 m2 had a significantly lower incidence of PPM with SEV compared with BEV, there was no significant difference in patients with BSA ≤1.83 m2. We found no impact of PPM on cardiovascular mortality or New York Heart Association functional class at 1 year.
CONCLUSIONS: SEV were associated with a lower frequency of PPM compared with BEV irrespective of annulus area. The difference was mainly driven by larger patients with BSA >1.83 m2.
Copyright © 2019 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  aortic stenosis; intra-annular valve; prosthesis-patient mismatch; supra-annular valve; transcatheter aortic valve replacement

Year:  2019        PMID: 31564593     DOI: 10.1016/j.jcin.2019.07.027

Source DB:  PubMed          Journal:  JACC Cardiovasc Interv        ISSN: 1936-8798            Impact factor:   11.195


  12 in total

1.  Hemodynamics of self-expanding versus balloon-expandable transcatheter heart valves in relation to native aortic annulus anatomy.

Authors:  Matti Adam; Victor Mauri; Sarah Schmidt; Vera Fortmeier; Sebastian Ludwig; Hendrik Wienemann; Maria Isabel Körber; Samuel Lee; Max Meertens; Sascha Macherey; Christos Iliadis; Elmar Kuhn; Kaveh Eghbalzadeh; Sabine Bleiziffer; Stephan Baldus; Niklas Schofer; Tanja Katharina Rudolph
Journal:  Clin Res Cardiol       Date:  2022-06-15       Impact factor: 5.460

Review 2.  Prosthesis-patient mismatch after transcatheter aortic valve implantation.

Authors:  Masaki Miyasaka
Journal:  Cardiovasc Interv Ther       Date:  2022-06-16

3.  10-Year Impact of Transcatheter Aortic Valve Replacement Leaflet Design (Intra- Versus Supra-Annular) in Mortality and Hemodynamic Performance.

Authors:  Andrea Scotti; Luca Nai Fovino; Augustin Coisne; Tommaso Fabris; Francesco Cardaioli; Mauro Massussi; Giulio Rodinò; Alberto Barolo; Mauro Boiago; Saverio Continisio; Carolina Montonati; Tommaso Sciarretta; Vittorio Zuccarelli; Valentina Bernardini; Giulia Masiero; Massimo Napodano; Chiara Fraccaro; Alfredo Marchese; Giovanni Esposito; Juan F Granada; Azeem Latib; Sabino Iliceto; Giuseppe Tarantini
Journal:  Front Cardiovasc Med       Date:  2022-06-08

4.  Transcatheter valve-in-valve implantation in degenerated aortic bioprostheses: are patients with small surgical bioprostheses at higher risk for unfavourable mid-term outcomes?

Authors:  Clarence Pingpoh; Holger Schroefel; Tanja Franz; Martin Czerny; Maximilian Kreibich; Martin Moser; Christoph Bode; Friedhelm Beyersdorf; Franz-Josef Neumann; Willibald Hochholzer; Matthias Siepe
Journal:  Ann Cardiothorac Surg       Date:  2020-11

5.  Incidence and predictors of prosthesis-patient mismatch after TAVI using SAPIEN 3 in Asian: differences between the newer and older balloon-expandable valve.

Authors:  Masaki Miyasaka; Norio Tada; Masataka Taguri; Shigeaki Kato; Yusuke Enta; Masaki Hata; Yusuke Watanabe; Toru Naganuma; Masahiro Yamawaki; Futoshi Yamanaka; Shinichi Shirai; Hiroshi Ueno; Kazuki Mizutani; Minoru Tabata; Kensuke Takagi; Masanori Yamamoto; Kentaro Hayashida
Journal:  Open Heart       Date:  2021-03

6.  Patient Prosthesis Mismatch After SAVR and TAVR.

Authors:  Sabine Bleiziffer; Tanja K Rudolph
Journal:  Front Cardiovasc Med       Date:  2022-03-30

7.  Hemodynamic Performance of Two Current-Generation Transcatheter Heart Valve Prostheses in Severely Calcified Aortic Valve Stenosis.

Authors:  Max Potratz; Kawa Mohemed; Hazem Omran; Lasha Gortamashvili; Kai Peter Friedrichs; Werner Scholtz; Smita Scholtz; Volker Rudolph; Cornelia Piper; Tomasz Gilis-Januszewski; René Schramm; Nobuyuki Furukawa; Jan Gummert; Sabine Bleiziffer; Tanja Katharina Rudolph
Journal:  J Clin Med       Date:  2022-08-05       Impact factor: 4.964

Review 8.  Clinical and Technical Challenges of Prosthesis-Patient Mismatch After Transcatheter Aortic Valve Implantation.

Authors:  Pier Pasquale Leone; Fabio Fazzari; Francesco Cannata; Jorge Sanz-Sanchez; Antonio Mangieri; Lorenzo Monti; Ottavia Cozzi; Giulio Giuseppe Stefanini; Renato Bragato; Antonio Colombo; Bernhard Reimers; Damiano Regazzoli
Journal:  Front Cardiovasc Med       Date:  2021-06-04

Review 9.  ACURATE neo: How Is This TAVR Valve Doing to Fit into an Increasingly Crowded Field?

Authors:  Taishi Okuno; Jonas Lanz; Thomas Pilgrim
Journal:  Curr Cardiol Rep       Date:  2020-08-08       Impact factor: 2.931

Review 10.  Trans-Catheter Valve-in-Valve Implantation for the Treatment of Aortic Bioprosthetic Valve Failure.

Authors:  Andrea Buono; Diego Maffeo; Giovanni Troise; Francesco Donatelli; Maurizio Tespili; Alfonso Ielasi
Journal:  J Clin Med       Date:  2022-01-11       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.